TIDMIMTK 
 
 
Imaginatik PLC 
11 October 2010 
 
? 
11 October 2010 
                                 Imaginatik plc 
                        ("Imaginatik" or the "Company") 
 
                         Contract Extension with Pfizer 
 
Imaginatik plc (AIM: IMTK.L), a leading provider of idea management software and 
innovation consultancy, is pleased to announce that it has signed a contract 
extension with Pfizer, Inc., one of the world's leading pharmaceutical 
companies. This contract extension builds on an existing annual agreement for 
Open Innovation with Pfizer and increases the annual recurring license fee. 
 
Matt Cooper, Executive Chairman of Imaginatik, commented "We are pleased to have 
again extended our relationship with Pfizer, a long standing customer of and 
investor in Imaginatik. We look forward to continuing our work with Pfizer and 
further supporting its innovation programme within its Research and Development 
division." 
 
For further information please contact: 
 
+-------------------------------------+--------------------+ 
| Imaginatik plc                      | Tel: 020 7917 2975 | 
+-------------------------------------+--------------------+ 
| Matthew Cooper, Chairman / Shawn    |                    | 
| Taylor, CFO                         |                    | 
+-------------------------------------+--------------------+ 
|                                     |                    | 
+-------------------------------------+--------------------+ 
| Arbuthnot Securities Limited        | Tel: 020 7012 2000 | 
+-------------------------------------+--------------------+ 
| Tom Griffiths                       |                    | 
+-------------------------------------+--------------------+ 
|                                     |                    | 
+-------------------------------------+--------------------+ 
| Threadneedle Communications         | Tel: 020 7653 9850 | 
+-------------------------------------+--------------------+ 
| Caroline Evans-Jones / Hilary       |                    | 
| Millar                              |                    | 
+-------------------------------------+--------------------+ 
 
 
About Imaginatik 
 
Imaginatik provides Innovation and idea management solutions to companies such 
as The Chubb Group of Insurance Companies, Boeing, Pfizer, Xerox, Goodyear and 
Cargill. Few companies possess the internal capability to consistently generate 
fresh ideas, identify those worth pursuing and reliably transform them into 
real, value-enhancing assets. This is Imaginatik's area of expertise. 
 
Imaginatik provides customers with strategic consulting, the award-winning Idea 
Central technology solution and an experienced, results-oriented innovation 
consulting team. 
 
Imaginatik is a public company whose shares are traded on the AIM market of the 
London Stock Exchange (LSE:IMTK.L) and a World Economic Forum Technology Pioneer 
with offices in Boston, MA, and London. In 2009, Imaginatik was named as one of 
the 500 fastest growing technology companies in the EMEA region by Deloitte. 
 
For more information visit www.imaginatik.com. 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 NRALLFILITLTIII
Abal (LSE:ABAL)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Abal Charts.
Abal (LSE:ABAL)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Abal Charts.